Zai Lab Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Greenshoe Option Read more about Zai Lab Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Greenshoe Option
Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary Shares Read more about Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary Shares
Zai Lab Announces Proposed Public Offering of American Depositary Shares Read more about Zai Lab Announces Proposed Public Offering of American Depositary Shares
Zai Lab Partner Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer Read more about Zai Lab Partner Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer
China NMPA Approves QINLOCK® (Ripretinib) for Treatment of Advanced Gastrointestinal Stromal Tumors (GIST) Read more about China NMPA Approves QINLOCK® (Ripretinib) for Treatment of Advanced Gastrointestinal Stromal Tumors (GIST)
Zai Lab and AlphaMa Biotech Entered Into an Agreement to Cooperate in New Drug Discovery Read more about Zai Lab and AlphaMa Biotech Entered Into an Agreement to Cooperate in New Drug Discovery
Zai Lab Announces Financial Results for Second-half and Full-year 2020 Read more about Zai Lab Announces Financial Results for Second-half and Full-year 2020
Zai Lab to Announce Full-Year 2020 Financial Results on March 1, 2021 Read more about Zai Lab to Announce Full-Year 2020 Financial Results on March 1, 2021
Zai Lab Announces Upcoming Presentations in February Investor Conferences Read more about Zai Lab Announces Upcoming Presentations in February Investor Conferences
Turning Point and Zai Lab Broaden Collaboration Read more about Turning Point and Zai Lab Broaden Collaboration